Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Asset Writedowns and Impairment (2020 - 2026)

Bioventus filings provide 6 years of Asset Writedowns and Impairment readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 601.68% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 96.21% decrease, with the full-year FY2025 number at $1.3 million, up 389.4% from a year prior.
  • Asset Writedowns and Impairment hit $1.3 million in Q4 2025 for Bioventus, up from -$650000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $79.3 million in Q4 2023 to a low of -$976000.0 in Q1 2024.
  • Median Asset Writedowns and Impairment over the past 5 years was $1.2 million (2022), compared with a mean of $8.0 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 759.41% in 2021 and later crashed 190.45% in 2024.
  • Bioventus' Asset Writedowns and Impairment stood at $7.2 million in 2021, then surged by 43.23% to $10.3 million in 2022, then skyrocketed by 671.12% to $79.3 million in 2023, then tumbled by 99.77% to $179000.0 in 2024, then skyrocketed by 601.68% to $1.3 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $1.3 million (Q4 2025), -$650000.0 (Q2 2025), and $650000.0 (Q1 2025) per Business Quant data.